| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |